1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Eisenmesser, E.Z.
Horita, D.A.
Altieri, A.S.
Byrd, R.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
310
231
241
10.1006/jmbi.2001.4765
11419949
Solution structure of interleukin-13 and insights into receptor engagement
2001
NE
J.BIOMOL.NMR
JBNME9
0800
0925-2738
19
93
94
10.1023/A:1008336103603
Secondary Structure and Backbone Resonance Assignments for Human Interleukin-13
2001
US
Protein Expr.Purif.
PEXPEJ
0757
1046-5928
20
186
195
10.1006/prep.2000.1283
Expression, Purification, Refolding, and Characterization of Recombinant Human Interleukin-13: Utilization of Intracellular Processing
2000
10.2210/pdb1ga3/pdb
pdb_00001ga3
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12416.438
Interleukin-13
1
man
polymer
IL-13, IL13
no
no
GGPVPPSTALRELIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAALESLINVSGCSAIEKTQRMLSGFCPHKVSAGQF
SSLHVRDTKIEVAQFVKDLLLHLKKLFREGRFN
GGPVPPSTALRELIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAALESLINVSGCSAIEKTQRMLSGFCPHKVSAGQF
SSLHVRDTKIEVAQFVKDLLLHLKKLFREGRFN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Human
Homo
Escherichia
Escherichia coli
sample
1
113
IL13, NC30
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21(DE3)
PLASMID
Biological sequence
PMAL-IL-13
database_2
pdbx_database_related
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
atom_site
entity
entity_name_com
entity_src_gen
pdbx_database_status
pdbx_nmr_exptl
pdbx_nmr_exptl_sample
pdbx_nmr_exptl_sample_conditions
pdbx_nmr_refine
pdbx_nmr_sample_details
pdbx_nmr_software
pdbx_struct_sheet_hbond
pdbx_validate_torsion
pdbx_version
struct
struct_conf
struct_keywords
struct_ref
struct_ref_seq
struct_ref_seq_dif
struct_sheet
struct_sheet_order
struct_sheet_range
database_2
pdbx_database_status
repository
Initial release
Model orientation/position
author
Coordinate replacement
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Atomic model
Data collection
Database references
Derived calculations
Experimental preparation
Other
Refinement description
Source and taxonomy
Structure summary
Database references
Other
1
0
2001-07-04
1
1
2008-04-27
1
2
2011-07-13
1
3
2019-12-25
2
0
2020-02-26
2
1
2023-06-14
_pdbx_database_status.status_code_cs
_struct_ref_seq_dif.details
_atom_site.Cartn_x
_atom_site.Cartn_y
_atom_site.Cartn_z
_entity.pdbx_description
_entity.pdbx_fragment
_entity_name_com.name
_entity_src_gen.gene_src_common_name
_entity_src_gen.pdbx_beg_seq_num
_entity_src_gen.pdbx_end_seq_num
_entity_src_gen.pdbx_gene_src_gene
_entity_src_gen.pdbx_host_org_strain
_entity_src_gen.pdbx_seq_type
_pdbx_database_status.SG_entry
_pdbx_nmr_exptl.sample_state
_pdbx_nmr_exptl.spectrometer_id
_pdbx_nmr_exptl_sample_conditions.ionic_strength_units
_pdbx_nmr_exptl_sample_conditions.label
_pdbx_nmr_exptl_sample_conditions.pH_units
_pdbx_nmr_refine.software_ordinal
_pdbx_nmr_sample_details.contents
_pdbx_nmr_sample_details.label
_pdbx_nmr_sample_details.type
_pdbx_nmr_software.authors
_pdbx_nmr_software.classification
_pdbx_nmr_software.version
_pdbx_struct_sheet_hbond.range_1_auth_atom_id
_pdbx_struct_sheet_hbond.range_1_label_atom_id
_pdbx_struct_sheet_hbond.range_2_auth_atom_id
_pdbx_struct_sheet_hbond.range_2_label_atom_id
_pdbx_struct_sheet_hbond.sheet_id
_struct.pdbx_CASP_flag
_struct_conf.pdbx_PDB_helix_id
_struct_keywords.text
_struct_ref.pdbx_align_begin
_struct_ref_seq.db_align_beg
_struct_ref_seq.db_align_end
_struct_ref_seq_dif.details
_struct_sheet.id
_struct_sheet_order.sheet_id
_struct_sheet_range.sheet_id
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
NMR STRUCTURE OF INTERLEUKIN-13
Y
RCSB
Y
RCSB
2000-11-29
REL
REL
REL
REL
Using 3D and 4D NMR.
structures with the lowest energy
200
20
isotropic
1
3D_15N-separated_NOESY
isotropic
1
3D_13C-separated_NOESY
isotropic
1
HNCACB
isotropic
1
CACBCONH
isotropic
2
4D CC-NOESY
isotropic
2
4D CN-NOESY
1
mM
[U-100% 13C; U-100% 15N]
25
mM
natural abundance
50
mM
natural abundance
1
mM
natural abundance
50mM NaCl
Not defined
cond1
6.1
pH
ambient
298
K
torsion angle dynamics
1
lowest energy
1 mM [U-100% 13C; U-100% 15N] IL-13, 25 mM phosphate buffer, 50 mM sodium chloride, 1 mM EDTA, 95% H2O/5% D2O
sample1
95% H2O/5% D2O
solution
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
Kraulis
data analysis
ANSIG
Brunger, Adams, Clore, Gros, Nilges and Read
structure calculation
CNS
Linge, O'Donoghue and Nilges
structure calculation
ARIA
Linge, O'Donoghue and Nilges
refinement
ARIA
500
Varian
INOVA
600
Varian
INOVA
GLY
1
n
1
GLY
1
A
GLY
2
n
2
GLY
2
A
PRO
3
n
3
PRO
3
A
VAL
4
n
4
VAL
4
A
PRO
5
n
5
PRO
5
A
PRO
6
n
6
PRO
6
A
SER
7
n
7
SER
7
A
THR
8
n
8
THR
8
A
ALA
9
n
9
ALA
9
A
LEU
10
n
10
LEU
10
A
ARG
11
n
11
ARG
11
A
GLU
12
n
12
GLU
12
A
LEU
13
n
13
LEU
13
A
ILE
14
n
14
ILE
14
A
GLU
15
n
15
GLU
15
A
GLU
16
n
16
GLU
16
A
LEU
17
n
17
LEU
17
A
VAL
18
n
18
VAL
18
A
ASN
19
n
19
ASN
19
A
ILE
20
n
20
ILE
20
A
THR
21
n
21
THR
21
A
GLN
22
n
22
GLN
22
A
ASN
23
n
23
ASN
23
A
GLN
24
n
24
GLN
24
A
LYS
25
n
25
LYS
25
A
ALA
26
n
26
ALA
26
A
PRO
27
n
27
PRO
27
A
LEU
28
n
28
LEU
28
A
CYS
29
n
29
CYS
29
A
ASN
30
n
30
ASN
30
A
GLY
31
n
31
GLY
31
A
SER
32
n
32
SER
32
A
MET
33
n
33
MET
33
A
VAL
34
n
34
VAL
34
A
TRP
35
n
35
TRP
35
A
SER
36
n
36
SER
36
A
ILE
37
n
37
ILE
37
A
ASN
38
n
38
ASN
38
A
LEU
39
n
39
LEU
39
A
THR
40
n
40
THR
40
A
ALA
41
n
41
ALA
41
A
GLY
42
n
42
GLY
42
A
MET
43
n
43
MET
43
A
TYR
44
n
44
TYR
44
A
CYS
45
n
45
CYS
45
A
ALA
46
n
46
ALA
46
A
ALA
47
n
47
ALA
47
A
LEU
48
n
48
LEU
48
A
GLU
49
n
49
GLU
49
A
SER
50
n
50
SER
50
A
LEU
51
n
51
LEU
51
A
ILE
52
n
52
ILE
52
A
ASN
53
n
53
ASN
53
A
VAL
54
n
54
VAL
54
A
SER
55
n
55
SER
55
A
GLY
56
n
56
GLY
56
A
CYS
57
n
57
CYS
57
A
SER
58
n
58
SER
58
A
ALA
59
n
59
ALA
59
A
ILE
60
n
60
ILE
60
A
GLU
61
n
61
GLU
61
A
LYS
62
n
62
LYS
62
A
THR
63
n
63
THR
63
A
GLN
64
n
64
GLN
64
A
ARG
65
n
65
ARG
65
A
MET
66
n
66
MET
66
A
LEU
67
n
67
LEU
67
A
SER
68
n
68
SER
68
A
GLY
69
n
69
GLY
69
A
PHE
70
n
70
PHE
70
A
CYS
71
n
71
CYS
71
A
PRO
72
n
72
PRO
72
A
HIS
73
n
73
HIS
73
A
LYS
74
n
74
LYS
74
A
VAL
75
n
75
VAL
75
A
SER
76
n
76
SER
76
A
ALA
77
n
77
ALA
77
A
GLY
78
n
78
GLY
78
A
GLN
79
n
79
GLN
79
A
PHE
80
n
80
PHE
80
A
SER
81
n
81
SER
81
A
SER
82
n
82
SER
82
A
LEU
83
n
83
LEU
83
A
HIS
84
n
84
HIS
84
A
VAL
85
n
85
VAL
85
A
ARG
86
n
86
ARG
86
A
ASP
87
n
87
ASP
87
A
THR
88
n
88
THR
88
A
LYS
89
n
89
LYS
89
A
ILE
90
n
90
ILE
90
A
GLU
91
n
91
GLU
91
A
VAL
92
n
92
VAL
92
A
ALA
93
n
93
ALA
93
A
GLN
94
n
94
GLN
94
A
PHE
95
n
95
PHE
95
A
VAL
96
n
96
VAL
96
A
LYS
97
n
97
LYS
97
A
ASP
98
n
98
ASP
98
A
LEU
99
n
99
LEU
99
A
LEU
100
n
100
LEU
100
A
LEU
101
n
101
LEU
101
A
HIS
102
n
102
HIS
102
A
LEU
103
n
103
LEU
103
A
LYS
104
n
104
LYS
104
A
LYS
105
n
105
LYS
105
A
LEU
106
n
106
LEU
106
A
PHE
107
n
107
PHE
107
A
ARG
108
n
108
ARG
108
A
GLU
109
n
109
GLU
109
A
GLY
110
n
110
GLY
110
A
ARG
111
n
111
ARG
111
A
PHE
112
n
112
PHE
112
A
ASN
113
n
113
ASN
113
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
VAL
34
A
N
VAL
34
A
O
ILE
90
A
O
ILE
90
1
A
PRO
3
-54.20
-171.18
1
A
GLN
24
-53.30
179.25
1
A
PRO
27
-78.46
-167.95
1
A
CYS
29
68.44
-82.59
1
A
ASN
30
-147.34
28.07
1
A
SER
36
-38.88
148.87
1
A
ASN
38
-113.87
55.55
1
A
LEU
39
-43.76
-19.87
1
A
ALA
41
-151.61
-85.93
1
A
CYS
57
-135.56
-68.53
1
A
GLU
61
-35.62
-37.56
1
A
CYS
71
-46.01
106.70
1
A
HIS
73
170.39
-165.77
1
A
SER
76
-115.11
-136.40
1
A
GLN
79
-168.02
47.90
1
A
SER
81
-147.74
30.51
1
A
ASP
87
-144.95
-83.10
1
A
LEU
101
-56.84
-70.51
1
A
ARG
111
-108.92
42.21
2
A
VAL
4
62.17
134.49
2
A
GLN
24
-54.08
171.94
2
A
CYS
29
64.92
-78.92
2
A
ASN
30
-150.26
31.12
2
A
SER
36
-39.26
146.34
2
A
ASN
38
-118.44
50.63
2
A
LEU
39
-35.26
-31.38
2
A
CYS
57
-135.08
-73.27
2
A
CYS
71
-46.56
106.38
2
A
HIS
73
167.71
-171.26
2
A
VAL
75
-166.48
98.12
2
A
SER
76
-105.17
-135.62
2
A
SER
81
-59.15
-175.25
2
A
HIS
84
-176.74
37.68
2
A
VAL
85
-166.22
67.78
2
A
ASP
87
-123.58
-80.59
2
A
ARG
111
23.45
48.07
3
A
GLN
24
-57.25
179.46
3
A
ALA
26
-47.67
152.33
3
A
SER
32
-164.73
108.32
3
A
SER
36
70.46
173.49
3
A
ASN
38
-117.62
73.88
3
A
THR
40
-165.29
-53.99
3
A
CYS
57
-139.70
-75.27
3
A
SER
58
75.23
-50.00
3
A
PRO
72
-82.43
49.27
3
A
HIS
73
177.49
-162.99
3
A
SER
76
-115.40
-136.16
3
A
SER
81
-176.31
126.35
3
A
SER
82
-59.67
-78.57
3
A
VAL
85
-168.60
96.61
3
A
ASP
87
-170.81
-79.18
3
A
ARG
111
-92.03
44.48
4
A
PRO
3
-52.42
-175.97
4
A
VAL
4
49.75
86.47
4
A
GLN
24
-54.87
-176.48
4
A
ASN
30
80.57
-51.13
4
A
SER
36
-39.26
149.72
4
A
LEU
39
-49.34
-12.81
4
A
ALA
41
-160.30
-91.23
4
A
CYS
57
-138.08
-76.17
4
A
HIS
73
-111.76
-140.82
4
A
VAL
75
-167.43
97.69
4
A
SER
76
-111.91
-136.18
4
A
ALA
77
-104.61
75.83
4
A
GLN
79
58.80
-170.17
4
A
PHE
80
-55.12
176.53
4
A
LEU
83
59.91
-176.22
4
A
ASP
87
-164.79
-87.23
4
A
LEU
101
-56.35
-70.17
4
A
ARG
111
23.17
48.71
5
A
PRO
3
-56.47
-163.37
5
A
VAL
4
51.41
84.04
5
A
PRO
6
-65.38
92.05
5
A
GLN
22
-115.50
59.43
5
A
ASN
23
-133.17
-81.68
5
A
ALA
26
-56.07
177.70
5
A
CYS
29
-127.79
-76.08
5
A
ASN
30
-159.09
28.63
5
A
MET
33
-49.29
163.03
5
A
SER
36
74.94
169.14
5
A
ASN
38
-91.86
55.78
5
A
LEU
39
-39.03
-26.58
5
A
ALA
41
-177.45
143.40
5
A
CYS
57
-133.36
-77.52
5
A
CYS
71
-42.86
100.62
5
A
VAL
75
-163.71
96.00
5
A
SER
76
-110.72
-136.04
5
A
GLN
79
43.13
89.48
5
A
SER
82
-176.61
-44.35
5
A
LEU
83
46.05
92.94
5
A
HIS
84
-126.61
-83.68
5
A
VAL
85
-177.32
100.38
5
A
ASP
87
-175.06
-87.07
5
A
ARG
111
23.26
48.00
6
A
VAL
4
50.25
87.90
6
A
PRO
6
-69.38
63.11
6
A
GLN
24
-57.07
-167.10
6
A
LEU
28
-57.50
-81.38
6
A
CYS
29
-97.69
-63.76
6
A
ASN
30
-154.75
53.76
6
A
SER
36
94.85
170.23
6
A
ASN
38
-109.75
69.10
6
A
THR
40
-172.19
-40.71
6
A
ALA
41
-165.37
116.00
6
A
CYS
57
-136.94
-66.20
6
A
HIS
73
171.00
-164.91
6
A
VAL
75
-166.97
97.78
6
A
SER
76
-96.10
-135.53
6
A
PHE
80
45.53
-89.70
6
A
HIS
84
78.43
-56.04
6
A
ASP
87
-170.26
-80.69
6
A
ARG
111
-91.81
43.41
7
A
VAL
4
62.04
134.48
7
A
ASN
23
-49.63
-85.59
7
A
ALA
26
-54.54
176.76
7
A
CYS
29
62.80
71.50
7
A
ASN
30
70.59
-54.25
7
A
SER
36
-40.39
159.98
7
A
ASN
38
-107.34
68.08
7
A
THR
40
-152.87
-46.20
7
A
ALA
41
-134.92
-79.84
7
A
CYS
57
-135.19
-68.48
7
A
GLU
61
-38.94
-38.71
7
A
CYS
71
-43.03
102.96
7
A
VAL
75
-167.68
97.41
7
A
SER
76
-115.79
-136.34
7
A
ALA
77
-110.97
63.18
7
A
GLN
79
-176.43
136.74
7
A
PHE
80
-101.40
-75.79
7
A
SER
81
55.92
-168.10
7
A
SER
82
63.97
-79.68
7
A
LEU
83
61.24
90.75
7
A
ASP
87
-103.22
-81.62
7
A
ARG
111
-105.41
43.68
8
A
VAL
4
49.43
88.29
8
A
CYS
29
83.32
-31.99
8
A
ASN
30
44.34
87.95
8
A
SER
32
-54.96
106.28
8
A
SER
36
-29.51
142.38
8
A
CYS
57
-137.87
-70.21
8
A
CYS
71
-35.86
97.71
8
A
HIS
73
168.05
-171.01
8
A
SER
76
-117.03
-136.81
8
A
GLN
79
-55.94
-170.86
8
A
PHE
80
-56.68
89.21
8
A
SER
81
-179.69
101.83
8
A
SER
82
70.47
-62.31
8
A
HIS
84
78.21
-56.35
8
A
VAL
85
-173.64
99.01
8
A
ASP
87
-134.39
-83.90
8
A
ARG
111
-91.54
42.63
9
A
PRO
3
-70.10
-168.06
9
A
VAL
4
50.02
79.29
9
A
PRO
6
-69.72
76.68
9
A
GLN
22
-104.96
-70.17
9
A
GLN
24
-66.63
77.95
9
A
CYS
29
62.63
-81.37
9
A
ASN
30
-169.38
35.42
9
A
MET
33
-46.03
162.84
9
A
SER
36
73.76
166.62
9
A
LEU
39
32.39
82.71
9
A
THR
40
-163.79
72.09
9
A
ALA
41
63.38
132.85
9
A
CYS
57
-127.25
-75.57
9
A
SER
58
57.74
19.29
9
A
HIS
73
-122.18
-145.88
9
A
VAL
75
-160.12
96.25
9
A
ALA
77
40.48
98.79
9
A
SER
81
-176.84
-40.37
9
A
HIS
84
-179.90
-36.91
9
A
ASP
87
-168.04
-81.97
10
A
VAL
4
62.12
134.21
10
A
PRO
6
-70.87
-167.81
10
A
GLN
22
-83.98
48.51
10
A
ALA
26
-52.99
171.85
10
A
CYS
29
62.59
-80.85
10
A
ASN
30
-143.02
-46.95
10
A
SER
36
-45.51
164.64
10
A
THR
40
-173.44
-53.92
10
A
VAL
54
-58.98
109.97
10
A
CYS
57
-129.33
-73.39
10
A
CYS
71
-47.45
107.20
10
A
HIS
73
169.91
-166.08
10
A
SER
76
-114.54
-136.52
10
A
SER
82
-173.73
-79.26
10
A
HIS
84
59.65
92.43
10
A
VAL
85
-106.23
-83.07
10
A
ARG
86
-175.13
138.12
10
A
ASP
87
-142.82
-82.64
11
A
VAL
4
49.59
88.31
11
A
GLN
22
-117.62
-73.38
11
A
ASN
23
-36.21
-33.78
11
A
LYS
25
76.35
-56.32
11
A
LEU
28
-96.21
-66.51
11
A
SER
32
-59.34
107.95
11
A
SER
36
63.76
169.91
11
A
LEU
39
29.79
81.92
11
A
THR
40
174.77
91.34
11
A
ALA
41
57.09
162.36
11
A
CYS
57
-131.93
-77.97
11
A
CYS
71
-43.84
103.63
11
A
HIS
73
179.43
-168.78
11
A
PHE
80
-139.19
-111.89
11
A
SER
81
53.98
-168.51
11
A
ARG
86
172.73
148.28
11
A
LEU
101
-51.68
-70.80
11
A
ARG
111
-97.57
42.52
12
A
VAL
4
-46.35
104.47
12
A
PRO
6
-69.46
-167.63
12
A
GLN
22
-91.55
41.67
12
A
GLN
24
-56.51
-176.31
12
A
LEU
28
-92.19
-84.43
12
A
ASN
30
44.11
80.93
12
A
SER
32
-164.83
106.05
12
A
TRP
35
-59.37
108.70
12
A
SER
36
-38.30
149.04
12
A
LEU
39
-39.80
-33.57
12
A
THR
40
-62.87
77.22
12
A
ALA
41
60.65
149.33
12
A
CYS
57
-130.27
-72.12
12
A
SER
58
58.50
19.60
12
A
HIS
73
-91.45
-157.99
12
A
VAL
75
-150.69
89.30
12
A
ALA
77
36.73
95.83
12
A
PHE
80
-112.25
53.95
12
A
SER
81
69.12
-67.60
12
A
HIS
84
-167.45
-42.68
12
A
VAL
85
42.19
75.60
12
A
ASP
87
-170.03
-92.82
12
A
ARG
111
-108.92
42.82
13
A
PRO
3
-53.20
-173.97
13
A
VAL
4
50.37
88.93
13
A
GLN
24
-56.30
-168.62
13
A
LEU
28
-115.06
-80.63
13
A
CYS
29
-79.39
-70.02
13
A
ASN
30
-165.10
31.46
13
A
SER
36
-38.34
146.16
13
A
ASN
38
-115.58
60.46
13
A
LEU
39
-39.76
-24.77
13
A
THR
40
-67.60
82.79
13
A
ALA
41
65.04
-86.69
13
A
CYS
57
-136.70
-79.16
13
A
HIS
73
-115.39
-93.65
13
A
LYS
74
175.85
148.14
13
A
VAL
75
-162.45
94.88
13
A
SER
76
-101.13
-136.82
13
A
SER
82
61.24
91.34
13
A
LEU
83
-98.71
34.03
13
A
HIS
84
-145.68
31.98
13
A
ASP
87
-94.59
-80.97
13
A
ARG
111
-97.81
43.58
14
A
ASN
23
-52.71
93.36
14
A
GLN
24
40.80
-167.50
14
A
ALA
26
-59.24
172.09
14
A
CYS
29
65.85
-76.09
14
A
ASN
30
-158.49
-45.04
14
A
SER
36
112.20
164.79
14
A
LEU
39
-39.93
-22.66
14
A
ALA
41
-128.17
-83.01
14
A
CYS
57
-132.60
-72.22
14
A
SER
58
59.12
19.22
14
A
HIS
73
-116.88
-147.41
14
A
VAL
75
-166.98
97.88
14
A
SER
76
-105.88
-135.63
14
A
GLN
79
59.55
-178.43
14
A
PHE
80
-148.34
44.93
14
A
SER
81
60.91
88.83
14
A
SER
82
-178.03
-38.80
14
A
HIS
84
-176.90
48.02
14
A
ARG
111
-89.20
42.96
15
A
PRO
3
-52.23
-176.97
15
A
GLN
24
-55.14
-171.67
15
A
PRO
27
-78.62
-168.31
15
A
LEU
28
-98.90
-87.81
15
A
ASN
30
44.14
79.85
15
A
SER
32
-165.33
107.47
15
A
TRP
35
-59.36
108.45
15
A
SER
36
-41.52
152.97
15
A
LEU
39
-33.27
-35.91
15
A
CYS
57
-133.39
-78.33
15
A
CYS
71
-43.26
102.95
15
A
HIS
73
178.56
-170.71
15
A
ALA
77
52.60
176.38
15
A
GLN
79
57.80
169.54
15
A
HIS
84
-156.95
29.36
15
A
VAL
85
-115.15
70.27
15
A
ASP
87
-144.53
-82.48
16
A
VAL
4
55.15
78.69
16
A
PRO
5
-59.99
173.27
16
A
PRO
6
-69.85
-167.49
16
A
GLN
22
-87.93
48.40
16
A
GLN
24
-55.01
-176.53
16
A
LEU
28
-85.47
-81.75
16
A
ASN
30
48.71
28.46
16
A
SER
32
-164.48
108.73
16
A
SER
36
75.05
166.64
16
A
ALA
41
-179.16
141.51
16
A
CYS
57
-133.35
-71.69
16
A
CYS
71
-42.25
103.34
16
A
VAL
75
-165.40
96.89
16
A
SER
76
-108.97
-136.96
16
A
ALA
77
-150.55
-84.55
16
A
GLN
79
63.20
86.65
16
A
PHE
80
-116.68
-82.46
16
A
SER
81
173.68
92.39
16
A
SER
82
57.54
-168.43
16
A
ASP
87
69.86
-4.25
16
A
LEU
101
-56.25
-70.45
17
A
VAL
4
-51.35
106.51
17
A
PRO
6
-69.44
77.63
17
A
GLN
22
-91.66
38.93
17
A
GLN
24
-52.30
-95.46
17
A
LEU
28
-81.65
-76.60
17
A
CYS
29
-147.03
38.09
17
A
ASN
30
-35.05
-34.00
17
A
SER
36
-34.67
150.06
17
A
ILE
37
-48.35
-175.78
17
A
ASN
38
-158.13
89.07
17
A
ALA
41
75.42
-61.65
17
A
CYS
57
-141.02
-59.37
17
A
HIS
73
-94.00
-154.78
17
A
ALA
77
-58.60
-166.44
17
A
GLN
79
-148.80
47.90
17
A
SER
82
-176.74
37.57
17
A
HIS
84
-168.38
57.63
17
A
ASP
87
-67.54
-84.26
18
A
PRO
3
-51.93
179.90
18
A
GLN
22
-104.86
63.79
18
A
ASN
23
-138.69
-83.96
18
A
GLN
24
-96.31
-95.39
18
A
ALA
26
79.32
40.75
18
A
LEU
28
-145.62
-79.41
18
A
SER
32
-167.53
107.46
18
A
SER
36
71.40
172.05
18
A
ASN
38
-104.02
71.00
18
A
THR
40
-148.42
-51.93
18
A
ALA
41
-141.64
-81.59
18
A
CYS
57
-130.62
-77.68
18
A
CYS
71
-44.51
103.83
18
A
HIS
73
178.96
-168.19
18
A
ALA
77
46.06
-172.24
18
A
GLN
79
62.68
165.04
18
A
SER
81
63.39
-79.37
18
A
ASP
87
-136.47
-81.22
19
A
GLN
22
-85.95
-75.78
19
A
ASN
23
-45.45
-75.68
19
A
GLN
24
-57.72
88.51
19
A
CYS
29
62.40
-81.71
19
A
ASN
30
-165.32
31.41
19
A
SER
36
79.78
174.01
19
A
ASN
38
-116.09
74.50
19
A
THR
40
-169.08
55.55
19
A
ALA
41
75.66
101.05
19
A
CYS
57
-133.18
-72.77
19
A
HIS
73
-99.09
-153.46
19
A
VAL
75
-166.50
98.04
19
A
ALA
77
-130.16
-75.62
19
A
GLN
79
-172.06
58.04
19
A
SER
81
-178.28
99.28
19
A
SER
82
-165.98
39.79
19
A
HIS
84
-155.16
34.80
19
A
VAL
85
-114.63
-81.75
19
A
ARG
86
58.95
108.33
19
A
ASP
87
-135.47
-80.81
20
A
VAL
4
49.71
84.23
20
A
GLN
24
-56.46
-174.58
20
A
ALA
26
-46.75
158.36
20
A
LEU
28
-86.72
-84.65
20
A
ASN
30
44.87
29.15
20
A
MET
33
-49.72
160.06
20
A
ASN
38
-113.42
58.38
20
A
LEU
39
-39.35
-26.78
20
A
CYS
57
-142.95
-64.42
20
A
CYS
71
-42.73
102.06
20
A
VAL
75
-166.06
97.45
20
A
SER
76
-106.58
-135.44
20
A
ALA
77
-54.35
-172.87
20
A
GLN
79
58.63
-170.89
20
A
SER
82
-176.09
36.91
20
A
LEU
83
-119.00
70.55
20
A
VAL
85
-127.41
-83.69
20
A
LEU
101
-56.66
-70.46
20
A
ARG
111
-92.87
42.97
N
NMR STRUCTURE OF INTERLEUKIN-13
1
N
N
A
SER
7
A
SER
7
HELX_P
A
GLN
22
A
GLN
22
1
AA1
16
A
MET
43
A
MET
43
HELX_P
A
ILE
52
A
ILE
52
1
AA2
10
A
ILE
60
A
ILE
60
HELX_P
A
GLY
69
A
GLY
69
1
AA3
10
A
GLU
91
A
GLU
91
HELX_P
A
GLY
110
A
GLY
110
1
AA4
20
disulf
2.030
A
CYS
29
A
SG
CYS
29
1_555
A
CYS
57
A
SG
CYS
57
1_555
disulf
2.031
A
CYS
45
A
SG
CYS
45
1_555
A
CYS
71
A
SG
CYS
71
1_555
CYTOKINE
cytokine
IL13_HUMAN
UNP
1
35
P35225
GPVPPSTALRELIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAALESLINVSGCSAIEKTQRMLSGFCPHKVSAGQFS
SLHVRDTKIEVAQFVKDLLLHLKKLFREGRFN
35
146
1GA3
2
113
P35225
A
1
2
113
1
expression tag
GLY
1
1GA3
A
P35225
UNP
1
2
anti-parallel
A
VAL
34
A
VAL
34
A
TRP
35
A
TRP
35
A
LYS
89
A
LYS
89
A
ILE
90
A
ILE
90